← Open Payments lookup

LINDSEY EDWARDS: Open Payments

NPI 1376295089 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,139 in 66 payments from 19 companies in 2025. Trend: 2023 $191 · 2024 $608 · 2025 $1,139

Food & beverage: $1,139
CompanyPaymentsAmount
Novo Nordisk Inc10$170
Astellas Pharma US Inc7$152
Bayer Healthcare Pharmaceuticals Inc.6$133
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)6$128
Lilly USA, LLC11$125
AstraZeneca Pharmaceuticals LP5$83
GlaxoSmithKline, LLC.4$72
PFIZER INC.4$65
Exact Sciences Corporation2$31
Boston Scientific Corporation2$29

Products named: Veozah, Kerendia, CAPLYTA, MOUNJARO, TRELEGY ELLIPTA, AIRSUPRA, Ozempic, KISUNLA.

Industry payments across IN — which companies pay providers there.